Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 254

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Perindopril for Elderly People with Chronic Heart Failure: The PEP-CHF Study

Cleland, John G.F., Tendera, Michal, Adamus, Jerzy, Freemantle, Nick, Gray, Christopher S., Lye, Michael, O’Mahony, Denis, Polonski, Lech, Taylor, Jacqueline·1999·European Journal of Heart Failure

Abstract

Background: The prevalence of chronic heart failure (CHF) rises with increasing age, from <1% in those below 65 years of age to > 5% in those over 65 years of age and is a major cause of morbidity and mortality in older people. Recent European guidelines point to a major deficiency in our knowledge of how to treat diastolic chronic heart failure, and a lack of information on treatment for heart failure in the elderly in general. Aims: The aims of this trial are to assess the potential benefits of the ACE inhibitor perindopril to treat chronic heart failure in elderly people, in the absence of any major left ventricular systolic dysfunction. Subjects: One thousand people over the age of 70 years will be recruited into this study. Evidence of chronic heart failure will be confirmed by clinical criteria and echocardiography. Methods: Once a diagnosis of chronic heart failure has been confirmed, the patient will receive either perindopril or placebo in addition to their usual treatment. Death, and unplanned heart failure related hospitalisations, are the primary outcomes. Quality of life, as measured by the Guyatt questionnaire will be assessed at the beginning of the study and at 1 year. Sub-studies of this trial include a 6-min walking test and more detailed evaluation of ventricular function (as assessed by echocardiography). Both parameters will be measured at 8 weeks and 1 year, and analysed against baseline data. Cognitive function in this group of patients will also be evaluated at baseline and 1 year. This trial is due to report in the year 2001.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1388-9842(99)00039-2

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Cited by

See all 254

Metadata

Authors
Cleland, J. G. F., Tendera, M., Adamus, J., Freemantle, N., Gray, C. S., Lye, M., O’Mahony, D., Polonski, L., & Taylor, J.
Venue
European Journal of Heart Failure
Published
1999-08-01
Volume
1
Issue
3
Pages
211-217
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2052544532
Cited by
254
References
35
FWCI
9.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Perindopril for Elderly People with Chronic Heart Failure: The PEP-CHF Study. https://app.cochat.ai/papers/10.1016/s1388-9842(99)00039-2
The paper
Cleland, J. G. F., Tendera, M., Adamus, J., Freemantle, N., Gray, C. S., Lye, M., O’Mahony, D., Polonski, L., & Taylor, J. (1999). Perindopril for Elderly People with Chronic Heart Failure: The PEP-CHF Study. European Journal of Heart Failure. https://doi.org/10.1016/s1388-9842(99)00039-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.